ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2009

Jun 9, 2009

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LTD ABN 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR ROBERT BARTLETT ELLIOTT
Date of last notice	11 MARCH 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT AND INDIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	DIRECTOR OF PANCELL LIMITED
Date of change	A) 9 MARCH 2009B) 18 MARCH 2008
No. of securities held prior to change	2,593,126 ORDINARY SHARES (HELD BYROBERT BARTLETT ELLIOTT)537,500 OPTIONS – CLASS A EXPIRING30/06/20101,485,800 OPTIONS – CLASS B EXPIRING30/06/2010350,000 OPTIONS - EXERCISABLE AT$0.30 PER SHARE, VESTING ON 9 MARCH2007 AND EXPIRING ON 9 MARCH 2009104,166 ORDINARY SHARES (HELD BYPANCELL LIMITED)
Class	A) OPTIONSB) SHARES

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number acquired	NIL
Number disposed	A) 350,000
	B) 104,166
Value/Consideration	$0.20 PER SHARE
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	2,593,126 ORDINARY SHARES (HELD BY
	ROBERT BARTLETT ELLIOTT)
	537,500 OPTIONS – CLASS A EXPIRING
	30/06/2010
	1,485,800 OPTIONS – CLASS B EXPIRING
	30/06/2010
Nature of change	A) LAPSED OPTIONS
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back	B)OFF MARKET TRADE

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002